C4 Therapeutics Inc

Finance

Barclays slashes price target on C4 Therapeutics Inc [CCCC] – find out why.

Edison Baldwin

C4 Therapeutics Inc [NASDAQ: CCCC] slipped around 0.0 points on Wednesday, while shares priced at $2.48 at the close of ...

Companies

why C4 Therapeutics Inc [CCCC] is a Good Choice for Investors After New Price Target of $15.00

Misty Lee

C4 Therapeutics Inc [NASDAQ: CCCC] surged by $0.26 during the normal trading session on Thursday and reaching a high of ...

Finance

Market Analysts see C4 Therapeutics Inc [CCCC] gaining to $8. Time to buy?

Brandon Evans

C4 Therapeutics Inc [NASDAQ: CCCC] price plunged by -3.15 percent to reach at -$0.07. A sum of 10139987 shares traded ...

DBT News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.